Search Within

Rachel Nicole Grisham

Formats
  1. Journal Article (80)
  2. Meeting Abstract (78)
  3. Review (9)
  4. Guidelines (3)
  5. Book Section (2)
  6. Editorial (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (175)
  2. GDMT, Medicine (175)
  3. Gynecologic Medicine Service (175)
  4. Gynecology Disease Management Team (175)
  5. Solid Tumor Oncology Division (175)
  6. Surgery (76)

More Groups

People
  1. Carol Aghajanian (87)
  2. Roisin O'Cearbhaill (68)
  3. Alexia Iasonos (63)
  4. Qin Zhou (56)
  5. Dennis Chi (52)
  6. Kara Long Roche (49)

More People

Years
  1. 2025 (13)
  2. 2024 (29)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (12)
  6. 2020 (21)

More Years

Publications
  1. Gynecologic Oncology (49)
  2. Journal of Clinical Oncology (37)
  3. International Journal of Gynecological Cancer (28)
  4. Clinical Cancer Research (8)
  5. Cancer (7)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (50)
  2. American Society of Clinical Oncology (42)
  3. Lippincott Williams & Wilkins (30)
  4. American Association for Cancer Research (10)
  5. Wiley Blackwell (8)
  6. Nature Publishing Group (6)

More Publishers

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer
    Journal Article

    Gordhandas, S. B.; Manning-Geist, B.; Henson, C.; Iyer, G.; Gardner, G. J.; Sonoda, Y.; Moore, K. N.; Aghajanian, C.; Chui, M. H.; Grisham, R. N.
    Scientific Reports (2022)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of low-grade serous cancers and associated clinical outcomes
    Meeting Abstract

    Manning-Geist, B.; Gordhandas, S.; Da Cruz Paula, A.; Weigelt, B.; Liu, Y.; Chui, H.; Grisham, R.
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Molecular results and potential biomarkers identified from MILO/ENGOT-ov11 phase 3 study of binimetinib versus physicians choice of chemotherapy (PCC) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Grisham, R. N.; Vergote, I.; Banerjee, S. N.; Drill, E. N.; Fabbro, M.; Mirza, M. R.; Romero, I.; Coleman, R. L.; Oza, A. M.; Hilpert, F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • ENGOT-ov60/GOG3052/RAMP 201: A phase 2 study of VS-6766 (dual RAF/MEK inhibitor) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Banerjee, S. N.; Monk, B. J.; Van Nieuwenhuysen, E.; Moore, K. N.; Oaknin, A.; Fabbro, M.; Colombo, N.; O'Malley, D. M.; Coleman, R. L.; Pachter, J. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel improves progression-free survival in patients with recurrent platinum-resistant ovarian cancer: A 3-arm, randomized, open-label, phase II study
    Meeting Abstract

    Colombo, N.; Nguyen, D. D.; Fleming, G. F.; Grisham, R. N.; Lorusso, D.; Van Gorp, T.; Oaknin, A.; Pashova, H. I.; Grauer, A.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy
    Journal Article

    Basaran, D.; Boerner, T.; Suhner, J.; Sassine, D.; Liu, Y.; Grisham, R. N.; Tew, W. P.; Gardner, G. J.; Zivanovic, O.; Sonoda, Y.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Spectrum of BRAF mutations and gene rearrangements in ovarian serous carcinoma
    Journal Article

    Chui, M. H.; Chang, J. C.; Zhang, Y.; Zehir, A.; Schram, A. M.; Konner, J.; Drilon, A. E.; da Cruz Paula, A.; Weigelt, B.; Grisham, R. N.
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • 10-year survival in patients diagnosed with high-grade epithelial ovarian cancer: A new metric for a new millennium
    Meeting Abstract

    Filippova, O.; Straubhar, A.; Lugo Santiago, N.; Zivanovic, O.; Gardner, G.; Tew, W.; O'Cearbhaill, R.; Grisham, R.; Sonoda, Y.; Roche, K. L.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary study
    Journal Article

    Boerner, T.; Walch, H. S.; Nguyen, B.; Iasonos, A.; Zhou, Q. C.; Schultz, N.; Chui, M. H.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save